DVXK ETF

$37.80
Leveraged fund≈2xWeights reflect notional exposure via swaps/derivatives and do not sum to 100%.
Net exposure
98.3%
Gross exposure
211.2%
Long
154.7%
Short
-56.4%
Cash & collateral
0.0%
As of Jun 30, 2026
Showing top 4 of 4 holdings(as of Jun 30, 2026)
#Ticker Name Weight Shares Mkt Value Share ChgPROSectorPROIndustryPRO
1-Zcs BRL 15.0359 01/24/25-01/02/29 Cme54.74%18,883$3.23M-OtherOther
2-Astrazeneca Plc 4.375 2045-11-1654.46%3,214,020$3.21M-OtherOther
3XLKTechnology Select Sector Spdr45.54%15,708$2.69MProProPro
4-3I Group Plc 3.75 2040-06-05 3.75 06/05/2040-56.41%-3,329,236$-3329236ProProPro

DVXK ETF All Holdings

DVXK holdings total 4 positions. The top 10 holdings account for 98.3% of the fund, led by Zcs BRL 15.0359 01/24/25-01/02/29 Cme at 54.7%, Astrazeneca Plc 4.375 2045-11-16 at 54.5%, Technology Select Sector Spdr at 45.5%.

DVXK portfolio concentration is relatively high, with the top 10 representing 98.3% of total assets. The largest sector exposure is Other at 52.8%.

DVXK sector allocation provides a detailed breakdown. DVXK overlap tool shows how holdings compare to other funds in your portfolio.

DVXK ETF Holdings

4 of 4 holdings

  • 1

    Zcs BRL 15.0359 01/24/25-01/02/29 Cme

    Other
    54.74%
  • 2

    Astrazeneca Plc 4.375 2045-11-16

    Other
    54.46%
  • 3

    Technology Select Sector Spdr

    XLKInformation Technology
    45.54%
  • 4

    3I Group Plc 3.75 2040-06-05 3.75 06/05/2040

    Other
    -56.41%